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Abstract: 
The paper presents the role of phototherapy in treatment of depression in pregnancy, 
puerperium and other selected psychiatric diseases. Bright light therapy can be used as an 
independent form of treatment or as a method supplementing pharmacotherapy. The treatment 
is based on the use of light that mimics natural sunlight during light therapy sessions. 
Phototherapy is an optimal solution when treating depressive moods, especially seasonal 
depression associated with deficiency of sunlight. In the autumn-winter season the production 
of serotonin responsible for the proper functioning of the nervous system and general well-
being, is physiologically reduced. Therefore, the use of light seems to be a reasonable 
treatment for depressive moods. Light therapy was also adopted in the treatment of 
schizophrenia, post-stroke depression and eating disorders. This method is characterized by 
high safety profile, a small number of mild side effects and a simple treatment scheme. In 
view of the above, it is a convenient method to be used in clinical conditions. 
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Introduction  
Phototherapy (bright light therapy) is one of the non-pharmacological methods of treatment 
used in psychiatry. It involves the use of light that mimics natural sunlight during light 
therapy sessions. Rosenthal first introduced it in the 1980s as one of the treatments for 
seasonal depression [1]. Seasonal depression is a disorder in which episodes of deteriorated 
mood occur in autumn-winter period. Ultraviolet light causes secretion of melatonin 
prohormone - serotonin, which, as a neurotransmitter, has a direct effect on mood, sleep, 
sexual impulsive behavior and appetite. The lack of natural light in the autumn-winter season 
largely contributes to the distortion the sleep and wakefulness rhythm, which in turn causes 
depressive symptoms by increasing the levels of melatonin. That is why the idea appeared of 
using light that mimics natural sunlight in the treatment of symptoms of depression [2,3]. 
The first phototherapy laboratory in Poland was established in 1991 at the Institute of 
Psychiatry and Neurology by Łukasz Święcicki, polish doctor, specialist in psychiatry. 
Numerous scientific studies have confirmed the efficacy and safety of phototherapy in the 
treatment of depressive disorders [4]. 
Research is currently being conducted on the application of phototherapy in the treatment of 
other mental diseases and disorders such as bipolar affective disorder, schizophrenia, eating 
disorders, depression in cancer patients or depression during pregnancy and after childbirth. 
Preliminary results are positive, pointing to promising possibilities in the treatment of 
depression of different origin [5]. 
Description of the method 
Phototherapy uses white light with a broad spectrum. To obtain the desired effect the lamp 
must be placed at eye level and emit light of a suitable brightness, most frequently of 5000-
10000 lux. The duration of a session depends on the brightness of the emitted light, for 
example for the light of 10000 lux the session lasts 30 minutes. To achieve effective 
depression treatment the appropriate light intensity and exposure time are required. The usual 
course of treatment involves several sessions taken every 1-2 days for the minimal duration of 
two weeks, with the optimal duration of the therapy lasting a few weeks [2, 4].  
Light therapy is used as a standalone treatment or it can support pharmacological therapy. It is 
safe and well tolerated by patients, provided that appropriate light sources with filters 
absorbing harmful ultraviolet radiation are used [2]. 
Side effects and precautions 
Research, including the one carried out in Poland [3], showed that phototherapy is usually 
well tolerated by patients. Side effects are usually mild and appear in approx. 30% of the 
cases [6]. The most common include headache, dizziness, nausea, blurred vision, eyestrain 
and watery eyes which usually persist for a few days and pass without any major 
complications. 
The treatment is not recommended for patients who take medications causing 
photosensitization, such as some antibiotics, antipsychotics, and herbal preparations 
containing St. John's wort. The consultation before starting the treatment should also take into 
account retinal diseases and the presence of migraines. It should also be noted that the use of 
phototherapy in patients suffering from bipolar affective disorder carries a higher risk of the 
phase change from depressive into maniac [2].  
Low cost of the therapy, favorable safety profile and simple treatment regimen encourage 
ongoing research on the applicability of phototherapy in various forms of depression and 
other mental disorders.  
The aim of the study 
The aim of the study is to review the current state of knowledge about the use of phototherapy 
in clinical practice, taking into account the indications, efficacy and safety of this method of 
treatment.  
306 
Current state of knowledge 
 
Seasonal Affective Disorder 
Since the prevalence of this type of depression increases with the increasing geographical 
latitude, it has been speculated that lower exposure to sunlight during autumn and winter 
months may contribute to the rise of seasonal depression. In this case, bright light therapy is 
recommended as a treatment of choice. Lack of natural light deregulates the circadian sleep-
wake rhythm and bringing it back to its regular pace results in a significant improvement in 
the functioning of patients in the autumn-winter period [4, 7].  
Circadian rhythm abnormalities 
Researchers are also interested in the use of light therapy as a supportive therapy to alleviate 
the effects of circadian rhythm abnormalities resulting from other medical conditions or 
intensive treatment. After phototherapy both women treated for breast cancer and patients 
with Alzheimer's disease have reported a marked improvement. Differences in the use of light 
therapy in these two groups of patients concerned the time of day – morning sessions for 
reducing the effects of chemotherapy and evening sessions using pulse light in Alzheimer's 
disease [7, 8]. 
Depression in pregnancy and puerperium 
Pregnancy is generally considered to be the state of specific mental welfare. However, the 
latest research and clinical practice clearly indicate the wrongs of this belief. In fact, high 
levels of anxiety are experienced by almost 60% of women in the third trimester of pregnancy 
[9]. As shown in scientific reports, currently depressive symptoms affect almost 20% of 
pregnant women [10]. The Ministry of Health took these disturbing reports very seriously, 
which resulted in including three obligatory checks of mental state of pregnant patients in the 
Organizational Standards of Perinatal Care. The first assessment of the risk of depressive 
symptoms and their possible exacerbation is supposed take place between the 11
th
 and 14
th
 
week of pregnancy, the second one between the 33
rd
 and 37
th
 week of pregnancy and last after 
giving birth [11]. Pregnant patients who demonstrated symptoms of a mental illness show an 
increased risk of developing a postpartum psychosis. Depressive episodes during pregnancy 
may contribute to the occurrence of premature births, which, in turn, results in prematurity 
and low birth weight of infants [12].  
Depression occurring during the pregnancy and after the childbirth is undoubtedly a very 
important issue. Along with the growing number of pregnant patients diagnosed with mental 
illnesses comes an increasing need for determining effective methods of treatment. 
The use of pharmacotherapy during pregnancy is limited due to the trans-placental 
transmission of antidepressants into the systemic circulation of the fetus. After labor the risk 
associated with the presence of the drug in the milk of breastfeeding mothers, must be taken 
into account. Little research has been carried out in this area, and in most cases the problem 
was associated with a small size of the study group and also ethical considerations [13, 14]. 
Limitation in the study resulted from the lack of observations concerning the reduction of 
fears, sleep problems or fatigue [14].  
Recent studies on pregnant women show that the light therapy alone, without psychotherapy 
and pharmacotherapy, brings very good results for mothers. No unwanted side effects such as 
premature birth, low birth weight and sudden infant death syndrome have been recorded.  
There are many scientific reports confirming the appropriateness of using electroconvulsive 
therapy in severe depressive states. This method provokes, however, a lot of controversy and 
therefore is relatively rarely used. 
Possible application of phototherapy in pregnant women and women in the postnatal period is 
currently being assessed. Due to the specific nature of this period and a broad spectrum of 
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complications, non-invasive, safe, affordable and available therapies for the treatment of 
depressive disorders are continuously being sought. 
Recent studies on pregnant women show that the light therapy alone, without psychotherapy 
and pharmacotherapy, brings very good results for mothers. No unwanted side effects such as 
premature birth, low birth weight and sudden infant death syndrome have been recorded. 
However, such situations are characteristic for the perinatal period in women with severe 
untreated depression [15]. 
Eating disorders 
Phototherapy is also used as a method of treatment of eating disorders in women. The 
effectiveness of phototherapy was examined in a study performed on a group of 24 female 
patients with anorexia and coexisting depression. Half of these patients in addition to the 
cognitive behavioral therapy were also subjected to phototherapy for 6 weeks (10000 lux for 
30 min). This group of patients demonstrated improvement in terms of a reduction in 
depressive symptoms unlike the group, which did not undergo phototherapy. There was 
however no significant difference in the increase of BMI between these both groups of 
patients [16].  
In another study on a group of patients with seasonal depression and coexisting bulimia, light 
therapy has also brought a significant improvement in mood. It has also been observed that 
the number of episodes of binge eating and self-induced vomiting decreased by 46% and 36% 
respectively. Two patients (9%) no longer experienced any episodes of binge eating and self-
induced vomiting, and 10 patients (45%) achieved remission of depressive symptoms [17].  
The existing results concerning the use of phototherapy in patients with eating disorders 
suggest that light therapy can be beneficial as a supportive therapy, but there is not enough 
data to recommend applying it as a first-line treatment [17, 18]. 
Depression in children  
Treatment of childhood and adolescent depression differs significantly from the treatment of 
depression in adults and one of the reasons may be immaturity of serotonergic and 
noradrenergic systems. Some of the drugs successfully used in the treatment of adults do not 
bring improvement in young patients [18]. A study carried out in 1990s in children with 
depression aged 7 to 17 years, showed the effectiveness of light therapy for  mood improved 
in both children and their parents [19]. 
Depression in older adults 
Elderly people have an increased risk of the occurrence of depressive moods, which can 
exacerbate the course of their other diseases. The concomitant high intake of drugs by these 
patients focuses attention on the use of light therapy as a prevention of polypharmacy (the 
simultaneous use of multiple medications). Light therapy patients (the residents of a long-term 
care centre) underwent the treatment every day for 4 weeks and it resulted in a marked 
improvement in their mental state as well as in the cognitive processes, sleep and circadian 
rhythms [20]. 
Post-stroke depression  
Post-stroke depression, experienced by approximately 30% of patients, affects the    
rehabilitation, which, as a result takes longer and is less effective. Citalopram therapy for 
depression was supported with light therapy. After 4 weeks of treatment the outcome 
measured using the Hamilton Depression Rating Scale confirmed a better improvement of 
treatment results in the group of patients using high-intensity light in comparison to the group 
under medium-intensity light therapy. Particularly significant improvement was observed 
among elderly patients [21]. 
Schizophrenia 
Encouraging results of the use of phototherapy in the treatment of depression led the 
researchers to look for the possible use of phototherapy in the treatment of the negative 
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symptoms and the coexisting depressive symptoms in schizophrenia. In one of the studies the 
improvement in terms of the reduction of the intensity of the negative symptoms has been 
confirmed in 10 patients with schizophrenia [22], however in another study the benefits of 
phototherapy in patients with schizophrenia have not found confirmation [23].  
Other diseases 
One of the studies showed an improvement in the mental state after applying phototherapy in 
patients undergoing rehabilitation for movement disorders. The aim of the study was to assess 
the effect of phototherapy in patients with symptoms of depression hospitalized in the ward 
for rehabilitation of orthopedic and neurological diseases. The patients were treated with 
kinesiotherapy and physiotherapy and additionally, for the purpose of the study, their faces 
were exposed to polarized light every day for 30 min during hospitalization. When the therapy 
finished the degree of depression severity was assessed using the Patients Health 
Questionnaire (PHQ-9). Lower degree of depression severity in the questionnaire was 
achieved in 93% of patients. The highest effectiveness of phototherapy was achieved in 
women with degenerative changes, and it proved least effective in a group of men diagnosed 
with a neurological disease [24]. 
The summary  
The studies carried out to date support the effectiveness of phototherapy in the treatment of 
seasonal depression and it is the currently used treatment of choice for this disease. Promising 
research results suggest the usefulness of this method of treatment in women with depression 
during pregnancy and after childbirth. However, there is still not enough data from large 
randomized studies to recommend this method as a first-line treatment. Phototherapy may 
also be used as a complementary therapy to the primary treatment of depression, which 
accompanies other diseases and mental disorders such as bipolar affective disorder, 
schizophrenia, eating disorders and post-stroke depression. 
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